Ingevity (NGVT) Liabilities and Shareholders Equity (2016 - 2025)
Ingevity (NGVT) has disclosed Liabilities and Shareholders Equity for 11 consecutive years, with $1.8 billion as the latest value for Q3 2025.
- On a quarterly basis, Liabilities and Shareholders Equity fell 17.08% to $1.8 billion in Q3 2025 year-over-year; TTM through Dec 2025 was $5.8 billion, a 36.46% decrease, with the full-year FY2024 number at $2.0 billion, down 22.9% from a year prior.
- Liabilities and Shareholders Equity was $1.8 billion for Q3 2025 at Ingevity, down from $1.9 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.8 billion in Q2 2023 to a low of $1.8 billion in Q3 2025.
- A 5-year average of $2.4 billion and a median of $2.4 billion in 2021 define the central range for Liabilities and Shareholders Equity.
- Peak YoY movement for Liabilities and Shareholders Equity: increased 19.54% in 2023, then dropped 22.9% in 2024.
- Ingevity's Liabilities and Shareholders Equity stood at $2.5 billion in 2021, then increased by 10.83% to $2.7 billion in 2022, then decreased by 4.14% to $2.6 billion in 2023, then decreased by 22.9% to $2.0 billion in 2024, then fell by 9.33% to $1.8 billion in 2025.
- Per Business Quant, the three most recent readings for NGVT's Liabilities and Shareholders Equity are $1.8 billion (Q3 2025), $1.9 billion (Q2 2025), and $2.1 billion (Q1 2025).